{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:36:39Z","timestamp":1791592599205,"version":"4.3.4"},"reference-count":32,"publisher":"Oncology Nursing Society (ONS)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJON"],"published-print":{"date-parts":[[2021,4,1]]},"DOI":"10.1188\/21.cjon.151-156","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T09:32:57Z","timestamp":1616146377000},"page":"151-156","source":"Crossref","is-referenced-by-count":9,"title":["Hazardous Drug Contamination: Presence of Bathroom Contamination in an Ambulatory Cancer Center"],"prefix":"10.1188","volume":"25","author":[{"given":"Seth","family":"Eisenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1302","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Arnold, S., & Kaup, H.M. (2019). Assessing variability of antineoplastic drugs handling practices in clinical settings. Journal of Occupational and Environmental Hygiene, 16(12), 757\u2013762. https:\/\/doi.org\/10.1080\/15459624.2019.1667502","DOI":"10.1080\/15459624.2019.1667502"},{"key":"2","doi-asserted-by":"crossref","unstructured":"B\u00f6hlandt, A., Groeneveld, S., Fischer, E., & Schierl, R. (2015). Cleaning efficiencies of three cleaning agents on four different surfaces after contamination by gemcitabine and 5-fluorouracil. Journal of Occupational and Environmental Hygiene, 12(6), 384\u2013392. https:\/\/doi.org\/10.1080\/15459624.2015.1009985","DOI":"10.1080\/15459624.2015.1009985"},{"key":"3","doi-asserted-by":"crossref","unstructured":"B\u00f6hlandt, A., Sverdel, Y., & Schierl, R. (2017). Antineoplastic drug residues inside homes of chemotherapy patients. International Journal of Hygiene and Environmental Health, 220(4), 757\u2013765. https:\/\/doi.org\/10.1016\/j.ijheh.2017.03.005","DOI":"10.1016\/j.ijheh.2017.03.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chauchat, L., Tanguay, C., Caron, N.J., Gagn\u00e9, S., Labr\u00e9che, F., & Bussi\u00e9res, J.F. (2019). Surface contamination with ten antineoplastic drugs in 83 Canadian centers. Journal of Oncology Pharmacy Practice, 25(5), 1089\u20131098. https:\/\/doi.org\/10.1177\/1078155218773862","DOI":"10.1177\/1078155218773862"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chu, W.C., Hon, C.Y., Danyluk, Q., Chua, P.P.S., & Astrakianakis, G. (2012). Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning. Journal of Oncology Pharmacy Practice, 18(1), 46\u201351. https:\/\/doi.org\/10.1177\/1078155211402106","DOI":"10.1177\/1078155211402106"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Connor, T.H., & Smith, J.P. (2016). New approaches to wipe sampling methods for antineoplastic and other hazardous drugs in healthcare settings. Pharmaceutical Technology in Hospital Pharmacy, 1(3), 107\u2013114. https:\/\/doi.org\/10.1515\/pthp-2016-0009","DOI":"10.1515\/pthp-2016-0009"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Fransman, W., Roeleveld, N., Peelen, S., de Kort, W., Kromhout, H., & Heederik, D. (2007). Nurses with dermal exposure to antineoplastic drugs: Reproductive outcomes. Epidemiology, 18(1), 112\u2013119. https:\/\/doi.org\/10.1097\/01.ede.0000246827.44093.c1","DOI":"10.1097\/01.ede.0000246827.44093.c1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Friese, C.R., McArdle, C., Zhao, T., Sun, D., Spasojevic, I., Polovich, M., & McCullagh, M.C. (2015). Antineoplastic drug exposure in an ambulatory setting: A pilot study. Cancer Nursing, 38(2), 111\u2013117. https:\/\/doi.org\/10.1097\/NCC.0000000000000143","DOI":"10.1097\/NCC.0000000000000143"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Gonzalez, R., & Massoomi, F. (2010). Manufacturers\u2019 recommendations for handling spilled hazardous drugs. American Journal of Health-System Pharmacy, 67(23), 1985\u20131986. https:\/\/doi.org\/10.2146\/ajhp100137","DOI":"10.2146\/ajhp100137"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Hedmer, M., J\u00f6nsson, B.A., & Nygren, O. (2004). Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces. Journal of Environmental Monitoring, 6(12), 979\u2013984. https:\/\/doi.org\/10.1039\/b409277e","DOI":"10.1039\/B409277E"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Hemminki, K., Kyyr\u00f6nen, P., & Lindbohm, M.L. (1985). Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome. Journal of Epidemiology and Community Health, 39(2), 141\u2013147. https:\/\/doi.org\/10.1136\/jech.39.2.141","DOI":"10.1136\/jech.39.2.141"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Hon, C.Y., Teschke, K., Demers, P.A., & Venners, S. (2014). Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system. Annals of Occupational Hygiene, 58(6), 761\u2013770. https:\/\/doi.org\/10.1093\/annhyg\/meu019","DOI":"10.1093\/annhyg\/meu019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hon, C.Y., Teschke, K., Shen, H., Demers, P.A., & Venners, S. (2015). Antineoplastic drug contamination in the urine of Canadian healthcare workers. International Archives of Occupational and Environmental Health, 88(7), 933\u2013941. https:\/\/doi.org\/10.1007\/s00420-015-1026-1","DOI":"10.1007\/s00420-015-1026-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Kromhout, H., Hoek, F., Uitterhoeve, R., Huijbers, R., Overmars, R.F., Anzion, R., & Vermeulen, R. (2000). Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Annals of Occupational Hygiene, 44(7), 551\u2013560. https:\/\/doi.org\/10.1016\/s0003-4878(00)00050-8","DOI":"10.1016\/S0003-4878(00)00050-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Lawson, C.C., Rocheleau, C.M., Whelan, E.A., Lividoti Hilbert, E.N., Grajewski, B., Spiegelman, D., & Rich-Edwards, J.W. (2012). Occupational exposures among nurses and risk of spontaneous abortion. American Journal of Obstetrics and Gynecology, 206(4), 36\u201337. https:\/\/doi.org\/10.1097\/01.aoa.0000426099.31929.92","DOI":"10.1097\/01.aoa.0000426099.31929.92"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Lorente, C., Cordier, S., Bergeret, A., De Walle, H.E.K., Goujard, J., Aym\u00e9, S., . . . Bianchi, F. (2000). Maternal occupational risk factors for oral clefts. Scandinavian Journal of Work, Environment and Health, 26(2), 137\u2013145. https:\/\/doi.org\/10.5271\/sjweh.523","DOI":"10.5271\/sjweh.523"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Marie, P., Christophe, C., Manon, R., Marc, M., Charleric, B., & Patrice, V. (2017). Environmental monitoring by surface sampling for cytotoxics: A review. Environmental Monitoring and Assessment, 189(2), 52. https:\/\/doi.org\/10.1007\/s10661-016-5762-9","DOI":"10.1007\/s10661-016-5762-9"},{"key":"18","unstructured":"Martin, S. (2005). Chemotherapy handling and effects among nurses and their offspring [Abstract]. Oncology Nursing Forum, 32(2), 425\u2013426."},{"key":"19","doi-asserted-by":"crossref","unstructured":"Mathias, P.I., Connor, T.H., & B\u2019Hymer, C. (2017). A review of high performance liquid chromatographic-mass spectrometric urinary methods for anticancer drug exposure of health care workers. Journal of Chromatography B, 1060, 316\u2013324. https:\/\/doi.org\/10.1016\/j.jchromb.2017.06.028","DOI":"10.1016\/j.jchromb.2017.06.028"},{"key":"20","unstructured":"Micromedex. (2020). IBM Watson Health information. https:\/\/bit.ly\/3bWwZBm"},{"key":"21","unstructured":"National Institute for Occupational Safety and Health. (2016). NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. https:\/\/bit.ly\/2OXbeZk"},{"key":"22","unstructured":"Occupational Safety and Health Administration. (2011). Occupational safety and health standards: Toxic and hazardous substances (Standard No. 1910.1020). https:\/\/www.osha.gov\/laws-regs\/regulations\/standardnumber\/1910\/1910.1020"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Pretty, J.R., Connor, T.H., Spasojevic, I., Kurtz, K.S., McLaurin, J.L., B\u2019Hymer, C., & Debord, D.G. (2012). Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment. Journal of Oncology Pharmacy Practice, 18(1), 23\u201336. https:\/\/doi.org\/10.1177\/1078155210389215","DOI":"10.1177\/1078155210389215"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Sessink, P.J.M., Anzion, R.B., Van den Broek, P.H.H., & Bos, R.P. (1992). Detection of contamination with antineoplastic agents in a hospital pharmacy department. Pharmaceutisch Weekblad, 14, 16\u201322. https:\/\/doi.org\/10.1007\/bf01989220","DOI":"10.1007\/BF01989220"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Shortridge, L.A., Lemasters, G.K., Valanis, B., & Hertzberg, V. (1995). Menstrual cycles in nurses handling antineoplastic drugs. Cancer Nursing, 18(6), 439\u2013444. https:\/\/doi.org\/10.1097\/00002820-199512000-00003","DOI":"10.1097\/00002820-199512000-00003"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Simon, N., Odou, P., Decaudin, B., Bonnabry, P., & Fleury-Souverain, S. (2019). Efficiency of degradation or desorption methods in antineoplastic drug decontamination: A critical review. Journal of Oncology Pharmacy Practice, 25(4), 929\u2013946. https:\/\/doi.org\/10.1177\/1078155219831427","DOI":"10.1177\/1078155219831427"},{"key":"27","unstructured":"U.S. Pharmacopeial Convention. (2017). General chapter  hazardous drugs\u2014Handling in healthcare settings. https:\/\/bit.ly\/3qZmv8K"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Valanis, B., Vollmer, W., Labuhn, K., & Glass, A. (1997). Occupational exposure to antineoplastic agents and self-reported infertility among nurses and pharmacists. Journal of Occupational and Environmental Medicine, 39(6), 574\u2013580. https:\/\/doi.org\/10.1097\/00043764-199706000-00013","DOI":"10.1097\/00043764-199706000-00013"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Viegas, S., Oliveira, A.C., Carolino, E., & P\u00e1dua, M. (2018). Occupational exposure to cytotoxic drugs: The importance of surface cleaning to prevent or minimise exposure. Archives of Industrial Hygiene and Toxicology, 69(3), 238\u2013249. https:\/\/doi.org\/10.2478\/aiht-2018-69-3137","DOI":"10.2478\/aiht-2018-69-3137"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Walton, A., Bush, M.A., Douglas, C., Allen, D.H., Polovich, M., & Spasojevic, I. (2020). Surface contamination with antineoplastic drugs on two inpatient oncology units. Oncology Nuring Forum, 47(3), 263\u2013272. https:\/\/doi.org\/10.1188\/20.ONF.263-272","DOI":"10.1188\/20.ONF.263-272"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Yuki, M., Ishida, T., & Sekine, S. (2015). Secondary exposure of family members to cyclophosphamide after chemotherapy of outpatients with cancer: A pilot study. Oncology Nursing Forum, 42(6), 665\u2013671. https:\/\/doi.org\/10.1188\/15.ONF.42-06AP","DOI":"10.1188\/15.ONF.42-06AP"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Yuki, M., Sekine, S., Takase, K., Ishida, T., & Sessink, P.J.M. (2013). Exposure of family members to antineoplastic drugs via excreta of treated cancer patients. Journal of Oncology Pharmacy Practice, 19(3), 208\u2013217. https:\/\/doi.org\/10.1177\/1078155212459667","DOI":"10.1177\/1078155212459667"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/cjon.ons.org\/cjon\/25\/2\/hazardous-drug-contamination-presence-bathroom-contamination-ambulatory-cancer-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:49:47Z","timestamp":1763754587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/25\/2\/hazardous-drug-contamination-presence-bathroom-contamination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1188\/21.cjon.151-156","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"value":"1092-1095","type":"print"},{"value":"1538-067X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}